Methylprednisolone pulse therapy compared with intravenous dexamethasone for severe COVID-19 patients: a randomized clinical trial
Abstract Background COVID-19, caused by SARS-CoV-2, leads to severe respiratory complications, often requiring intensive care. Corticosteroids have been widely used to manage inflammation in COVID-19 patients, with dexamethasone and methylprednisolone being among the most commonly administered optio...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Virology Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12985-025-02906-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|